使用生物仿真载体传递mRNA:进展和挑战
Menghao Yin1, Hanruo Sun1, Yanan Li1
1School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, China.
Small (Weinheim an der Bergstrasse, Germany)
|July 15, 2024
概括
使者RNA (mRNA) 疗法面临着交付方面的挑战. 生物仿真载体提供生物相容的解决方案,用于有效的体内mRNA输送,推进治疗应用.
科学领域:
- 生物医学工程 生物医学工程
- 治疗输送系统 治疗输送系统
- 分子医学是分子医学.
背景情况:
- 使者RNA (mRNA) 代表了对各种疾病的有前途的治疗方式.
- mRNA的临床应用受到其固有的不稳定性和低效的细胞吸收阻碍.
- 有效的传递系统对于目标细胞和组织的体内mRNA表达至关重要.
研究的目的:
- 审查基于生物模拟载体的mRNA输送策略.
- 讨论生物仿真载体相对于传统传递系统的优势.
- 探索仿生mRNA传递系统在生物医学领域的挑战和未来前景.
主要方法:
- 基于生物模拟载体的mRNA传递系统的文献综述.
- 对仿生载体的特性和优势的分析 (生物相容性,准).
- 讨论当前的挑战和该领域的未来方向.
主要成果:
- 生物仿真载体显示出高生物相容性和组织特异性向能力.
- 这些载体显示出在体内有效的mRNA传递的潜力,克服了裸体mRNA的局限性.
- 该审查综合了关于mRNA疗法生物仿真方法的现有知识.
结论:
- 生物仿真载体是克服mRNA传递障碍的有希望的策略.
- 对仿生载体设计和应用的进一步研究可以显著推进基于mRNA的疗法.
- 本综述为未来生物医学应用提供了对仿生系统的潜力和挑战的见解.
相关概念视频
01:09Recombinant DNA
104.9K
Overview
104.9K
02:15Experimental RNAi
8.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K